US Healthcare
America’s Healthcare Cost Crisis
The United States is facing an accelerating health-economic emergency. With nearly $4.9 trillion in annual spending (CMS National Health Expenditure Data, 2024) — more than any country in the world — the U.S. continues to underperform on life expectancy, chronic disease management, and health equity relative to other OECD nations. Despite unparalleled spending, outcomes continue to erode.
US Healthcare
A System That Outspends Its Results
-
$4.9 trillion in national health expenditures (CMS, 2024)
-
17.6% of GDP allocated to healthcare (CMS, 2024)
-
Per-capita spend of $14,570, more than double most peer nations (OECD Health Statistics)
This level of spending is structurally unsustainable and crowds out investment in education, infrastructure, and economic competitiveness.
US Healthcare
A Trillion Dollars
Lost to Waste
A landmark JAMA analysis (2019) identified $760–$935 billion in annual waste across:
-
administrative complexity
-
care coordination failures
-
overtreatment
-
pricing inefficiencies
-
fraud and abuse
-
underuse of prevention
The Deloitte Center for Health Solutions found that only ~12% of clinical data is ever used, meaning the majority of potentially life-saving, cost-saving insights remain untapped.
Cost Drivers
Medication Non-Adherence
$528 Billion
annually due to non-adherence
(New England Journal of Medicine; CDC estimates).
Fragmented Data
$300–$350 Billion
in waste across the healthcare industry
(Deloitte Center for Health Solutions, 2020).
Poor Diabetes Control
$900–$3,800 PMPY
through early detection & proactive interventions
(McKinsey).
Avoidable Hospitalizations
$30.8 Billion
annually in preventable expenses
(Agency for Healthcare Research & Quality).
Proactive Care Management
$900–$3,800
PMPY cost reduction through early detection and proactive interventions
(McKinsey).
US Healthcare
Everyone Tried to Fix Healthcare.
No One Tried to Pay It Differently.
For decades, healthcare built new tools—apps, dashboards, AI, care programs. Most worked, but none changed system behavior because they never changed incentives. Healthcare doesn’t fail from lack of solutions; it fails because solutions don’t alter economics.
PULZ doesn’t add another tool to a broken structure — it changes what the system is rewarded for. Despite $100B+ invested, costs and outcomes barely moved due to persistent incentive misalignment.
US Healthcare
Systems Behave Exactly How They’re Paid to Behave.
Healthcare already knows how to improve outcomes, but costs keep rising because clinical insights never changed how money moves. PULZ solves that missing layer. It is designed to become the economic engine of healthcare—turning health signals and human behavior into measurable value and finally aligning payers, partners, and members around shared financial outcomes. Evidence-based pathways exist, predictive models work, but economic misalignment remains the primary barrier to real system change.
US Healthcare
Data Was Never the Problem. Value Was.
Healthcare produces massive amounts of clinical, diagnostic, and behavioral data. The problem was never collection — it was conversion. PULZ doesn’t gather data just to display insights; it turns health signals into economic signals that create, measure, and distribute value across the ecosystem. With patient data fragmented across 16+ systems, only ~12% analyzed, and $300–$350B lost annually, The key potential lies in unlocking the economic value of health data
Economic Impact Report
The PULZ Economic Impact Report provides a detailed and deliberately conservative assessment of how a precision-health economic operating system could reshape the U.S. healthcare landscape.
Across key stakeholder groups — including payers, employers, providers, wellness partners, pharmaceutical organizations, government programs, and individual patients — the analysis points to a consistent conclusion:
$260-B$510B
Estimated annual national value unlocked
Across payers, employers, providers, pharma, wellness partners, government programs, and patients under realistic adoption scenarios
$120B–$260B
Annual value opportunity for government programs
Driven by reduced preventable hospitalizations, chronic disease escalation, and unmanaged behavioral risk across Medicare, Medicaid, and public health systems
$180B–$300B
Annual economic impact for employers
From lower healthcare spend and recovered productivity tied to improved workforce health
$40B–$90B
Annual value for payers & health plans
Through reduced avoidable medical expenditure, improved adherence, and stabilized population risk
$30B–$55B
Annual value for providers
From improved care alignment, reduced downstream escalation, and better readiness in value-based environments
$10B–$21B
Annual value for pharma and research organizations
Through lower trial recruitment costs, faster enrollment, & higher-quality real-world evidence
$9B–$19B
Annual value for wellness and consumer health partners
From precision activation, higher conversion, and more efficient customer acquisition
$530B+
Annual productivity losses linked to chronic disease
Representing one of the largest hidden economic burdens on the U.S. economy